Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03386513
Title Study of IMGN632 in Patients With Relapse/Refractory AML, BPDCN, ALL, Other CD123+ Hem Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ImmunoGen, Inc.

acute myeloid leukemia

acute lymphoblastic leukemia

myeloproliferative neoplasm

hematologic cancer

chronic myeloid leukemia

aggressive NK-cell leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.